Venture CapitalRIA · CRD 332045SEC-RegisteredPrivate Fund Adviser

Updated:

Humain Ventures

Humain Ventures invests in early-stage AI and enterprise software companies that enhance human capability from its base in San Francisco.

Humain Ventures logo

Humain Ventures

Humain Ventures backs founders at the intersection of AI, therapeutics, biosensing, and prevention-first healthcare.

General information

Firm type

Venture Capital

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

San Francisco

Corporate office

San Francisco, CA, United States

Sector focus

Enterprise SoftwareAI/MLDigital HealthFinTech

Frequently asked questions

What is Humain Ventures' core investment thesis?

Humain Ventures invests in early-stage companies that combine artificial intelligence with human-centric design, pursuing a thesis that technology businesses which augment — rather than replace — human capability will prove most defensible over time. The firm focuses on applied AI, enterprise software, and digital health sectors where human judgment and machine intelligence compound. This philosophy guides both its sourcing and portfolio support (per the firm's official communications).

At what stage does Humain Ventures typically invest?

The firm targets pre-seed and seed-stage opportunities, providing early capital to founding teams that have a clear vision for how AI integrates with human workflows. Humain Ventures structures its investments as direct equity, with a preference for leading or co-leading rounds at the earliest institutional inflection point. It maintains a concentrated portfolio to allow for meaningful post-investment engagement.

Which sectors does Humain Ventures explicitly focus on?

Humain Ventures concentrates on applied AI platforms, enterprise software, and digital health. Within these domains, it looks for companies building clinical decision support tools, enterprise workflow automation, and developer platforms that embed AI as a collaborative layer. The firm evaluates opportunities based on the defensibility of the human-AI interface and the technical moat underpinning the product.

How does Humain Ventures source its deal flow?

As an early-stage investor based in San Francisco, Humain Ventures sources opportunities through founder networks, technical communities, and co-investor relationships within the Bay Area startup ecosystem. Its concentrated, thesis-driven approach attracts entrepreneurs who are building for regulated or high-stakes environments where human oversight remains mission-critical, allowing the firm to compete for allocation in competitive seed rounds.

Does Humain Ventures lead rounds or participate as a co-investor?

Humain Ventures is structured to move quickly on term sheets and can act as either a lead or co-investor, depending on round dynamics and syndicate composition. The firm's emerging-manager profile and operational flexibility enable it to partner alongside institutional seed funds and angel investors, with a decision-making process designed for the pace of early-stage technology markets.

What is Humain Ventures' geographic focus?

The firm invests primarily in North American companies, with a strong emphasis on the San Francisco Bay Area and other major US technology hubs. Humain Ventures' proximity to Bay Area talent and its integration into the local startup network inform its sourcing strategy, though it evaluates exceptional teams across the United States that fit its human-centric AI thesis.

How does Humain Ventures differentiate itself from other early-stage AI investors?

Humain Ventures distinguishes itself through thematic concentration on the human-AI interface rather than on AI infrastructure or pure automation. The firm's philosophy holds that commercial durability in AI-native companies will correlate with how carefully they design for human oversight and domain expertise — a stance that resonates with founders targeting regulated industries or complex professional environments where fully autonomous systems face adoption barriers.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More San Francisco Venture Capital profiles